REG - RWS Holdings PLC - Directorate Change

RWS HoldingsAnnouncement

05/07/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220705:nRSE2862Ra&default-theme=true

RNS Number : 2862R  RWS Holdings PLC  05 July 2022

RNS - Appointment of Chief Financial Officer

 

 

For immediate release
 
 
 
 
 5 July 2022

 

RWS Holdings plc

 

Board Change

Appointment of Chief Financial Officer

 

 

RWS Holdings plc ("RWS" or "the Group"), a unique world-leading provider of
technology-enabled language, content and intellectual property services,
announces the appointment of Candida (Candy) Davies as Chief Financial Officer
with effect from 1 October 2022. She will join the Board and the Group
Executive Team.

 

Candy was most recently Head of Finance for the Personal Health division of
Royal Philips, the Dutch-headquartered health technology conglomerate, where
she also supported the Group Innovation and Strategy function. She has
considerable experience in commercial and operational leadership and played a
key role in driving market innovation, new business models and solutions to
support enhancing patient and consumer experience, improving health outcomes,
and driving sustainable performance. Prior to this she spent eight years at
Reckitt Benckiser, latterly as European Finance Director for the Hygiene and
Home Business Unit, having previously been Senior Vice President and Corporate
Controller for the group. Earlier in her career, she spent twelve years with
Eli Lilly & Co, having gained chartered accountant status at KPMG.

 

Ian El-Mokadem, Chief Executive Officer, commented:

 

"I am delighted that we have appointed Candy as Chief Financial Officer. Her
international, blue-chip and health sector experience combined with her
expertise across finance, strategy and innovation will be invaluable to the
Board and the Executive team, as we continue to focus on delivering our
accelerated growth plan."

 

Candy Davies, Chief Financial Officer designate, commented:

 

"I look forward to joining RWS and working with its leadership team to build
on its strong client relationships, ability to offer a unique blend of
services and technology at scale, and leading position in large, attractive,
growing markets, to deliver on its medium-term growth strategy."

 

Rod Day will continue as Interim CFO and complete a thorough handover before
leaving RWS by the end of 2022.

 

Other than the previous directorships set out at the end of this announcement,
there is no further information required to be disclosed pursuant to paragraph
(g) of Schedule Two of the AIM Rules for Companies, in relation to Candy
Davies's appointment to the Board.

 

For further information, please contact:

 RWS Holdings plc

 Andrew Brode, Chairman

 Ian El-Mokadem, Chief Executive Officer                01753 480200

 Rod Day, Chief Financial Officer

 MHP (Financial PR advisor)                             rws@mhpc.com

 Katie Hunt / Simon Hockridge                           020 3128 8100

 Numis (Nomad & Joint Broker)

 Stuart Skinner / Kevin Cruickshank / Will Baunton      020 7260 1000

 Berenberg (Joint Broker)

 Ben Wright / Toby Flaux / Alix Mecklenburg-Solodkoff   020 3207 7800

About RWS:

RWS Holdings plc is a unique, world-leading provider of technology-enabled
language, content and intellectual property services. Through content
transformation and multilingual data analysis, our unique combination of
technology and cultural expertise helps our clients to grow by ensuring they
are understood anywhere, in any language.

Our purpose is unlocking global understanding. By combining cultural
understanding, client understanding and technical understanding, our services
and technology assist our clients to acquire and retain customers, deliver
engaging user experiences, maintain compliance and gain actionable insights
into their data and content.

Our clients include 90 of the world's top 100 brands, the top 20
pharmaceutical companies and 19 of the top 20 patent filers. Our client base
spans Europe, Asia Pacific and North and South America. We work in the
automotive, chemical, financial, legal, medical, pharmaceutical, technology
and telecommunications sectors, which we serve from 80+ global locations
across five continents.

Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM,
the London Stock Exchange regulated market (RWS.L).

For further information, please visit: www.rws.com.

 

Candy Davies (aged 48) holds or has held directorships in the five years
preceding her appointment at the Company as follows:

Current:

None

Last 5 years:

Reckitt Benckiser Healthcare (CIS) Limited

Reckitt Benckiser USA (2010) LLC

R&C Nominees Limited

Reckitt & Colman Holdings Limited

Reckitt Benckiser USA Finance (No.3) Limited

Reckitt & Sons Limited

Reckitt Benckiser Finance (2005) Limited

Hamol Limited

RB Reigate (UK) Limited

Reckitt Benckiser Holdings (USA) Limited

Reckitt Benckiser USA Finance (No.1) Limited

Reckitt Benckiser Healthcare (Mema) Limited

Reckitt & Colman Pension Trustee Limited

Reckitt Benckiser Luxembourg (No.3) Limited

ERH Propack Limited

Reckitt Benckiser Treasury (2007) Limited

Reckitt Benckiser Finance Company Limited

Reckitt Benckiser Luxembourg (No.1) Limited

Reckitt Benckiser (USA) Limited

Reckitt Benckiser Asia Pacific Limited

R&C Nominees One Limited

RB Holdings (Nottingham) Limited

Reckitt Benckiser Service Bureau Limited

Glasgow Square Limited

Howard Lloyd & Company Limited

R&C Nominees Two Limited

Reckitt Colman Chiswick (OTC) Limited

Reckitt & Colman (UK) Limited

Reckitt Benckiser USA Finance (No.2) Limited

Reckitt Benckiser Luxembourg (No.4) Limited

Reckitt Benckiser Healthcare (Central & Eastern Europe) Limited

Suffolk Finance Company Limited

Lloyds Pharmaceuticals

Crookes Healthcare Limited

Green, Young & Company Limited

Optrex Limited

Nurofen Limited

Reckitt Benckiser Holdings (Overseas) Limited

Helpcentral Limited

Reckitt Benckiser Luxembourg (No.2) Limited

Reckitt Benckiser Investments Limited

Reckitt Benckiser (Grosvenor) Holdings Limited

W. Woodward Limited

SSL (RB) Products Limited

Reckitt Seton Limited

Cupal Limited

Sonet Products Limited

Dakin Brothers Limited

Scholl Consumer Products Limited

Durex Limited

Reckitt & Colman Trustee Services Limited

SSL (SD) International Limited

Scholl (Investments) Limited

Seton Healthcare No.1 Trustee Limited

SSL (C C Services) Limited

British Surgical Industries Limited

New Bridge Street Invoicing Limited

SSL (MG) Products Limited

Rivalmuster

Sonet Group Limited

Open Championship Limited

Earex Products Limited

Brevet Hospital Products (UK) Limited

Ultra Chemical Limited

Sonet Scholl Healthcare Limited

Ultra Laboratories Limited

Sonet Scholl Healthcare International Limited

Seton Healthcare Group No.2 Trustee Limited

Sonet Healthcare Limited

SSL (C C Manufacturing) Limited

Prebbles Limited

LRC Investments Limited

29 St Leonard's Avenue Limited

Reckitt & Colman (Overseas) Limited

Reckitt Benckiser Limited

SSL International Plc

Reckitt Benckiser Treasury Services Plc

Reckitt Benckiser Jersey (No.2) Limited

Sonet Overseas Investments Limited

Reckitt Benckiser Holdings (Luxembourg) Limited

Reckitt Benckiser Jersey (No.3) Limited

Reckitt Benckiser Jersey (No.1) Limited

RB (China Trading) Limited

RB Mexico Investments Limited

RB Asia Holding Limited

Reckitt Benckiser (Rumea) Limited

Reckitt Benckiser (Brands) Limited

Reckitt Benckiser Corporate Services Limited

RB Luxembourg (2016) Limited

MJ UK Holdings Limited

RB Reigate (2019) Limited

RB USA (2019) Limited

Reckitt Benckiser (Cayman Islands) Limited

Reckitt Benckiser Jersey (No.5) Limited

Reckitt & Colman (Jersey) Limited

Reckitt & Colman Capital Finance Limited

SSL Capital Limited

Reckitt Benckiser USA (2013) LLC

Reckitt Benckiser Asia Pacific Limited - Japan Branch

Reckitt Benckiser Holdings (USA) Limited - Luxembourg branch

The French's Food Finance Company Limited - Luxembourg branch

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAFFFIFDAISIIF